Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,041 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,668 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00122005 | GVAX in Advanced Prostate Cancer Patients Made Lymphopenic | unknown | Phase 1 / Phase 2 | 18 | Providence Health & ServicesOTHER | 1 | Feb 24, 2009 | clinicaltrials |
| NCT00204633 | Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) | completed | Phase 2 | 108 | University Hospital TuebingenOTHER | 1 | Feb 16, 2009 | clinicaltrials |
| NCT00113789 | Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer | completed | Phase 2 | 21 | AmgenINDUSTRY | 0 | Feb 13, 2009 | clinicaltrials |
| NCT00111618 | Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer | completed | Phase 2 | 70 | Antisoma ResearchINDUSTRY | 1 | Jan 30, 2009 | clinicaltrials |
| NCT00826891 | Study of Cisplatin in Cervical Cancer Stage IVB | unknown | Phase 2 | 40 | Chinese Anti-Cancer AssociationOTHER | 0 | Jan 22, 2009 | clinicaltrials |
| NCT00018538 | Calcifidol Therapy in Men With Cancer | completed | Phase 2 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00657982 | Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer | unknown | Phase 2 | 15 | Sheba Medical CenterOTHER_GOV | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00167648 | Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer(NE2) | completed | Phase 2 | 17 | University of WashingtonOTHER | 1 | Jan 19, 2009 | clinicaltrials |
| NCT00174863 | Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer(ODYSSEY) | completed | Phase 2 | 232 | SanofiINDUSTRY | 13 | Dec 23, 2008 | clinicaltrials |
| NCT00127465 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | completed | Phase 1 / Phase 2 | 400 | University of PlymouthOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00394810 | Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 2 | 21 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00400348 | Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer | completed | Phase 2 | 18 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00090376 | Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy | completed | Phase 2 | 240 | Eisai Inc.INDUSTRY | 1 | Nov 7, 2008 | clinicaltrials |
| NCT00772694 | Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy(GCT) | unknown | Phase 2 | 20 | Fondation Wygrajmy ZdrowieOTHER | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00772798 | A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer | unknown | Phase 2 | 70 | Herlev HospitalOTHER | 1 | Oct 15, 2008 | clinicaltrials |
| NCT00546039 | Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer | unknown | Phase 2 | 47 | University Hospital, AkerOTHER | 1 | Sep 30, 2008 | clinicaltrials |
| NCT00069901 | Phase II CT-2103/Carboplatin in Ovarian Cancer | completed | Phase 2 | 82 | CTI BioPharmaINDUSTRY | 1 | Sep 22, 2008 | clinicaltrials |
| NCT00104130 | Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer | terminated | Phase 2 | 53 | Bristol-Myers SquibbINDUSTRY | 1 | Sep 17, 2008 | clinicaltrials |
| NCT00425204 | Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | completed | Phase 2 | 31 | AmgenINDUSTRY | 0 | Sep 15, 2008 | clinicaltrials |
| NCT00024414 | DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075543 | Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer | unknown | Phase 1 / Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00150644 | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy | completed | Phase 2 | 33 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00087854 | Study of Individualized Amonafide to Treat Prostate Cancer | completed | Phase 1 / Phase 2 | 40 | Xanthus Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 23, 2008 | clinicaltrials |
| NCT00108290 | Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer | completed | Phase 2 | — | US Department of Veterans AffairsFED | 1 | Apr 4, 2008 | clinicaltrials |
| NCT00001266 | A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001427 | A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001446 | A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00278070 | Metronomic Oral Vinorelbine in Patients With Metastatic Tumors | completed | Phase 2 | — | Hellenic Cooperative Oncology GroupOTHER | 1 | Feb 29, 2008 | clinicaltrials |
| NCT00064610 | Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer | completed | Phase 1 / Phase 2 | 102 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00612495 | Endometrial Cancer - LOHP Alone and With 5FU | completed | Phase 2 | 31 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00405574 | Study of ATN-224 in Patients With Prostate Cancer | unknown | Phase 2 | 50 | AttenuonINDUSTRY | 1 | Jan 30, 2008 | clinicaltrials |
| NCT00087841 | Self-Hypnotic Relaxation Therapy During Invasive Procedures | completed | Phase 2 | 390 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 17, 2008 | clinicaltrials |
| NCT00072930 | MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer | completed | Phase 2 | 150 | MedImmune LLCINDUSTRY | 7 | Jan 15, 2008 | clinicaltrials |
| NCT00157560 | Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma | completed | Phase 2 | 83 | Massachusetts General HospitalOTHER | 1 | Jan 3, 2008 | clinicaltrials |
| NCT00121030 | Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00140348 | Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine | completed | Phase 1 / Phase 2 | 80 | Cell GenesysINDUSTRY | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00121095 | Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer | unknown | Phase 1 / Phase 2 | 69 | Cytogen CorporationINDUSTRY | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00034138 | A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma | terminated | Phase 1 / Phase 2 | 24 | Unither PharmaceuticalsINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00034372 | Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma | terminated | Phase 2 | 102 | Unither PharmaceuticalsINDUSTRY | 2 | Dec 18, 2007 | clinicaltrials |
| NCT00086632 | Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment | terminated | Phase 2 | 40 | Unither PharmaceuticalsINDUSTRY | 0 | Dec 18, 2007 | clinicaltrials |
| NCT00138138 | Psychostimulants for Fatigue in Prostate Cancer | completed | Phase 2 | 120 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 10, 2007 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00245895 | Study of Aranesp to Treat Anemia in Prostate Cancer Patients. | completed | Phase 2 | 20 | University of WashingtonOTHER | 1 | Nov 29, 2007 | clinicaltrials |
| NCT00283829 | Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 30 | University of WashingtonOTHER | 1 | Nov 29, 2007 | clinicaltrials |
| NCT00551577 | Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial(PRIMOVAR-1) | unknown | Phase 2 | 100 | University Hospital, BonnOTHER | 1 | Oct 31, 2007 | clinicaltrials |
| NCT00418080 | Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy | completed | Phase 2 | 86 | University of L'AquilaOTHER | 1 | Oct 8, 2007 | clinicaltrials |
| NCT00421694 | Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide | completed | Phase 2 / Phase 3 | 119 | University of L'AquilaOTHER | 1 | Oct 8, 2007 | clinicaltrials |
| NCT00539669 | TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian | completed | Phase 2 | 47 | SanofiINDUSTRY | 1 | Oct 4, 2007 | clinicaltrials |
| NCT00115635 | Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 60 | Herlev HospitalOTHER | 1 | Oct 2, 2007 | clinicaltrials |
| NCT00401635 | END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin | completed | Phase 2 | 42 | National Cancer Institute, NaplesOTHER | 1 | Sep 5, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Feb 24, 2009source: clinicaltrials